A new Class of Drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments

Citation
L. Weissfloch et al., A new Class of Drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments, BIOMETALS, 14(1), 2001, pp. 43-49
Citations number
20
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOMETALS
ISSN journal
09660844 → ACNP
Volume
14
Issue
1
Year of publication
2001
Pages
43 - 49
Database
ISI
SICI code
0966-0844(200103)14:1<43:ANCODF>2.0.ZU;2-O
Abstract
A new class of drugs, borylated derivatives of ferrocenium compounds, which show a comparatively facile synthesis is investigated on their boron neutr on capture accumulation. Investigations focused on the fast and effective t esting of 12 ferrocene derivatives with tetracoordinated boron atoms, which should accumulate in rodent tumors. The macroscopic studies on time-depend ent boron distributions and boron concentrations in mice were carried out b y inductively coupled plasma-atomic emission spectrometry, inductively coup led plasma-mass spectrometry, and quantitative neutron capture radiography. The determination of boron concentrations after injection of 2b showed hig h boron contents in spleen, liver, kidneys, less in lung and muscle, and po or in integral blood, blood plasma, tumor, and brain. It is interesting to note that 2b penetrates the blood-brain barrier which may be advantageous i n the treatment of astrocytomas and glioblastomas.